ArticleScientific reports2026
Morphological abnormalities in the ureter of type XVII collagen-deficient mice.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Non-fibrillar type XVII collagen (COL17A1) is a hemidesmosomal component of the epidermis and a key skin-disease molecule. We previously reported that COL17A1 is expressed in the urothelium of multiple species at low constitutive or in inducible levels. To clarify its function in the ureter, Col17a1-knockout (KO) mice were examined from 2 to 12 weeks of age. After 4 weeks, Col17a1-KO mice showed shorter ureteral length, smaller cross-sectional area, and disorganized urothelial layers compared with wild-type littermates, accompanied by systemic growth retardation. At 4 and/or 12 weeks, Col17a1-KO urothelium exhibited a higher epithelial area ratio, loss of polarity, intraluminal cells, lumen narrowing, and indistinct mucosal folds. Abnormalities were evident as early as 2 weeks, particularly in umbrella cells, which showed altered apical surfaces, hypertrophy, smaller vesicles, and shortened interdigitations. RNA-seq of 2-week-old Col17a1-KO ureters revealed upregulation of immune-related genes and downregulation of epithelial development genes. Uroplakin 2, a key urothelial molecule, was reduced in Col17a1-KO ureters at 1 day and 2 weeks but not at 12 weeks. Its transcription factor, forkhead box protein A1, was persistently reduced, with markedly lower protein expression in umbrella cells. These findings indicate that urothelial COL17A1 is essential for proper urothelial differentiation during postnatal development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.